irofulven has been researched along with cytochrome c-t in 1 studies
Studies (irofulven) | Trials (irofulven) | Recent Studies (post-2010) (irofulven) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
---|---|---|---|---|---|
99 | 22 | 7 | 11,809 | 21 | 5,125 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herman, TS; Kosakowska-Cholody, T; Leal, BZ; Liang, H; Michejda, CJ; Salinas, RA; Waters, SJ; Woynarowska, BA; Woynarowski, JM | 1 |
1 other study(ies) available for irofulven and cytochrome c-t
Article | Year |
---|---|
Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Bridged Bicyclo Compounds; Caspases; Cell Line, Tumor; Cell Proliferation; Cytochromes c; DNA Fragmentation; Enzyme Inhibitors; Humans; Male; Mitochondria; Molecular Structure; Prostatic Neoplasms; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Signal Transduction | 2004 |